Sermoreline (GHRH 1–29) – Growth Hormone Research Peptide
Sermoreline is a synthetic Growth Hormone Releasing Hormone (GHRH) analogue
used in endocrinological and biochemical research.
In in-vitro laboratory models, this peptide stimulates the
release of growth hormone (HGH) from the pituitary gland via
GHRH receptors.
Sermoreline is widely studied in the context of
cell growth, aging-related mechanisms, and metabolic regulation.
Sermoreline is produced according to strict laboratory quality standards and verified using
High-Performance Liquid Chromatography (HPLC) to ensure a purity of
≥ 99%.
Each batch is intended exclusively for controlled scientific research applications.
Key specifications
| Specification | Value / description |
|---|---|
| Name | Sermoreline (GHRH 1–29) |
| Molecular formula | C149H246N44O42S |
| Molecular weight | ≈ 3,357 Da |
| Form | Lyophilized powder |
| Purity | ≥ 99% (HPLC tested) |
| Storage conditions | Store refrigerated, protected from light and moisture |
Research relevance
- Studied for its role in growth hormone release and pituitary function.
- Key research model for investigating GHRH receptor activity and endocrine signaling pathways.
- Often evaluated alongside peptides such as GHRP-2 or Ipamorelin in comparative laboratory research.
